Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 8/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12259929 | 0.96 | APLNR (0.54) | APLNROPRD1OPRM1OPRK1 | |
| SCHEMBL29904128 | 0.95 | APLNR (0.51) | APLNROPRD1OPRM1OPRK1 | |
| SCHEMBL30039271 | 0.87 | OPRM1 (0.55) | APLNROPRM1OPRK1 | |
| SCHEMBL30019693 | 0.87 | OPRD1 (0.48) | APLNROPRD1 | |
| SCHEMBL29421978 | 0.85 | APLNR (0.51) | APLNROPRD1OPRM1OPRK1 | |
| SCHEMBL30602837 | 0.85 | NTSR1 (0.55) | OPRD1OPRM1 | |
| SCHEMBL29904044 | 0.85 | OPRM1 (0.55) | APLNROPRM1OPRK1 | |
| SCHEMBL38655507 | 0.85 | OPRM1 (0.55) | APLNROPRM1OPRK1 | |
| SCHEMBL30522715 | 0.85 | CXCR4 (0.50) | APLNROPRD1OPRM1OPRK1 | |
| SCHEMBL22380749 | 0.85 | APLNR (0.52) | APLNROPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096830-B2 | Multi-layered hydrogel constructs and associated methods | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-08-04 | — | — | US | disclosed |
| US-20110262493-A1 | MULTI-LAYERED HYDROGEL CONSTRUCTS AND ASSOCIATED METHODS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262493-A1 | MULTI-LAYERED HYDROGEL CONSTRUCTS AND ASSOCIATED METHODS | CD44, MMP13, MMP3 | APLNR 2026/4885OPRD1 4693/4885OPRM1 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.